The allegations put forth by this plaintiff echo so much of what we have heard from our own clients. We look forward to the jury’s decision in this case, as the outcome will aid in evaluating similar transvaginal mesh lawsuits.
New York, New York (PRWEB) August 15, 2013
Transvaginal mesh lawsuits (http://www.vaginalmeshlawsuit2015.com/) filed against C.R. Bard, Inc. and other pelvic mesh manufacturers continue to move forward in courts around the country, Bernstein Liebhard LLP reports. According to Bloomberg.com, jury deliberations are now underway in the first federal trial of a C.R. Bard vaginal mesh lawsuit. During closing statements earlier this week, an attorney for the plaintiff told the panel of four men and four women that executives at C.R. Bard knew that the plastic used to manufacture its Avaulta line of pelvic mesh came with a warning that it shouldn’t be permanently implanted in humans, but still pushed ahead with production. The Plaintiff in the case, a 45-year-old public health nurse from Georgia, claims that she suffered serious complications and was forced to undergo multiple corrective procedures due to the Avaulta Plus device she received in 2009 to treat pelvic organ prolapse.* (Cisson v. C.R. Bard Inc., 11-cv-00195, U.S. District Court, Southern District of West Virginia (Charleston))
“The allegations put forth by this plaintiff echo so much of what we have heard from our own clients. We look forward to the jury’s decision in this case, as the outcome will aid in evaluating similar transvaginal mesh lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffery S. Grand, serves on the Plaintiffs’ Steering Committee in the federal C.R. Bard litigation. Bernstein Liebhard LLP continues to offer free mesh lawsuit consultations to women who allegedly suffered serious injuries following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.
Vaginal Mesh Lawsuits
Court documents indicate that C.R. Bard is named in more than 5,000 transvaginal mesh lawsuits, most of which are pending in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia. The case currently at trial is one of four bellwether cases scheduled in that proceeding. All of the lawsuits claim that transvaginal mesh products marketed by C.R. Bard to treat pelvic organ prolapse and stress urinary incontinence were defective, and caused women to suffer serious vaginal mesh complications, including mesh erosion, chronic pain, scarring and infection. Plaintiffs further allege that C.R. Bard failed to provide adequate warnings to doctors and patients about these risks. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)
The C.R. Bard litigation is just one of several pending in the Southern District of West Virginia for vaginal mesh lawsuits. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees for the following federal litigations: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327.
Mr. Grand is also serving as Co-Liaison Counsel in two consolidated litigations established for C.R. Bard and Ethicon mesh lawsuits in New Jersey’s Atlantic Superior Court. He was also a member of the trial team on the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
C.R. Bard and other pelvic mesh manufacturers have been the subject of growing litigation since 2008, when the U.S. Food & Drug Administrations (FDA) issued the first of two Public Health Alerts concerning a high rate of serious complications among women who received transvaginal mesh implants in surgeries to repair pelvic organ prolapse and stress urinary incontinence. In a second alert released in July 2011, the agency declared that injuries associated with their use in prolapse repair could no longer be considered rare.
Women who suffered serious injuries following implantation of transvaginal mesh to treat pelvic organ prolapse or stress urinary incontinence may be entitled to compensation for their medical bills, lost wages, pain and suffering and other damages. Learn More about vaginal mesh complications at Bernstein Liebhard LLP’s website. For a free legal consultation with one of the Firm’s attorneys, please call 800-511-5092.
*bloomberg.com/news/2013-08-13/bard-put-profits-ahead-of-patients-safety-lawyer-says.html; Bloomberg.com, August 13, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP